vs
PATHWARD FINANCIAL, INC.（CASH）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是PATHWARD FINANCIAL, INC.的1.8倍（$493.8M vs $276.3M），PATHWARD FINANCIAL, INC.净利率更高（26.4% vs 6.8%，领先19.6%），过去两年PATHWARD FINANCIAL, INC.的营收复合增速更高（21.0% vs -0.1%）
Pathward Financial, Inc.是一家总部位于美国的银行及金融服务企业，其前身为Meta金融集团旗下相关业务主体，2022年母公司将“Meta”商标出售给Meta Platforms后，正式启用现有名称。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
CASH vs MD — 直观对比
营收规模更大
MD
是对方的1.8倍
$276.3M
净利率更高
CASH
高出19.6%
6.8%
两年增速更快
CASH
近两年复合增速
-0.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $276.3M | $493.8M |
| 净利润 | $72.9M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | — | 9.9% |
| 净利率 | 26.4% | 6.8% |
| 营收同比 | — | -1.7% |
| 净利润同比 | — | 10.5% |
| 每股收益（稀释后） | $3.35 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CASHMD
| Q1 26 | $276.3M | — | ||
| Q4 25 | $173.1M | $493.8M | ||
| Q3 25 | $186.7M | $492.9M | ||
| Q2 25 | $195.8M | $468.8M | ||
| Q1 25 | $274.8M | $458.4M | ||
| Q4 24 | $182.6M | $502.4M | ||
| Q3 24 | $179.5M | $511.2M | ||
| Q2 24 | $188.6M | $504.3M |
净利润CASHMD
| Q1 26 | $72.9M | — | ||
| Q4 25 | $35.2M | $33.7M | ||
| Q3 25 | $38.8M | $71.7M | ||
| Q2 25 | $42.1M | $39.3M | ||
| Q1 25 | $75.0M | $20.7M | ||
| Q4 24 | $30.0M | $30.5M | ||
| Q3 24 | $33.5M | $19.4M | ||
| Q2 24 | $44.9M | $-153.0M |
营业利润率CASHMD
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | 9.9% | ||
| Q3 25 | 25.9% | 13.8% | ||
| Q2 25 | 24.1% | 12.8% | ||
| Q1 25 | 33.2% | 7.0% | ||
| Q4 24 | 19.8% | 7.8% | ||
| Q3 24 | 20.9% | 6.6% | ||
| Q2 24 | 27.1% | -31.3% |
净利率CASHMD
| Q1 26 | 26.4% | — | ||
| Q4 25 | 20.3% | 6.8% | ||
| Q3 25 | 20.8% | 14.5% | ||
| Q2 25 | 21.5% | 8.4% | ||
| Q1 25 | 27.3% | 4.5% | ||
| Q4 24 | 16.4% | 6.1% | ||
| Q3 24 | 18.7% | 3.8% | ||
| Q2 24 | 23.8% | -30.3% |
每股收益（稀释后）CASHMD
| Q1 26 | $3.35 | — | ||
| Q4 25 | $1.57 | $0.40 | ||
| Q3 25 | $1.69 | $0.84 | ||
| Q2 25 | $1.81 | $0.46 | ||
| Q1 25 | $3.14 | $0.24 | ||
| Q4 24 | $1.23 | $0.37 | ||
| Q3 24 | $1.34 | $0.23 | ||
| Q2 24 | $1.78 | $-1.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.6M | $375.2M |
| 总债务越低越好 | $59.5M | $570.5M |
| 股东权益账面价值 | $850.7M | $865.9M |
| 总资产 | $7.1B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资CASHMD
| Q1 26 | $157.6M | — | ||
| Q4 25 | $331.2M | $375.2M | ||
| Q3 25 | $120.6M | $340.1M | ||
| Q2 25 | $258.3M | $224.7M | ||
| Q1 25 | $254.2M | $99.0M | ||
| Q4 24 | $597.4M | $229.9M | ||
| Q3 24 | $158.3M | $103.8M | ||
| Q2 24 | $298.9M | $19.4M |
总债务CASHMD
| Q1 26 | $59.5M | — | ||
| Q4 25 | $33.5M | $570.5M | ||
| Q3 25 | $33.5M | $577.2M | ||
| Q2 25 | $33.4M | $583.9M | ||
| Q1 25 | $33.4M | $590.5M | ||
| Q4 24 | $33.4M | $597.1M | ||
| Q3 24 | $33.4M | — | ||
| Q2 24 | $33.3M | — |
股东权益CASHMD
| Q1 26 | $850.7M | — | ||
| Q4 25 | $854.5M | $865.9M | ||
| Q3 25 | $858.0M | $890.7M | ||
| Q2 25 | $819.0M | $833.8M | ||
| Q1 25 | $814.7M | $789.2M | ||
| Q4 24 | $758.3M | $764.9M | ||
| Q3 24 | $822.5M | $732.5M | ||
| Q2 24 | $748.4M | $706.5M |
总资产CASHMD
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.6B | $2.2B | ||
| Q3 25 | $7.2B | $2.2B | ||
| Q2 25 | $7.2B | $2.1B | ||
| Q1 25 | $7.0B | $2.0B | ||
| Q4 24 | $7.6B | $2.2B | ||
| Q3 24 | $7.5B | $2.1B | ||
| Q2 24 | $7.5B | $2.0B |
负债/权益比CASHMD
| Q1 26 | 0.07× | — | ||
| Q4 25 | 0.04× | 0.66× | ||
| Q3 25 | 0.04× | 0.65× | ||
| Q2 25 | 0.04× | 0.70× | ||
| Q1 25 | 0.04× | 0.75× | ||
| Q4 24 | 0.04× | 0.78× | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CASHMD
| Q1 26 | — | — | ||
| Q4 25 | $108.3M | $114.1M | ||
| Q3 25 | $303.7M | $137.3M | ||
| Q2 25 | $30.4M | $137.2M | ||
| Q1 25 | $188.3M | $-117.5M | ||
| Q4 24 | $-71.7M | $133.0M | ||
| Q3 24 | $143.1M | $91.8M | ||
| Q2 24 | $113.2M | $107.0M |
自由现金流CASHMD
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | — | ||
| Q3 25 | $300.3M | — | ||
| Q2 25 | $27.7M | — | ||
| Q1 25 | $184.7M | — | ||
| Q4 24 | $-73.8M | — | ||
| Q3 24 | $138.8M | — | ||
| Q2 24 | $111.0M | — |
自由现金流率CASHMD
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | — | ||
| Q3 25 | 160.9% | — | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | 67.2% | — | ||
| Q4 24 | -40.4% | — | ||
| Q3 24 | 77.3% | — | ||
| Q2 24 | 58.8% | — |
资本支出强度CASHMD
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.2% | — |
现金转化率CASHMD
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 3.39× | ||
| Q3 25 | 7.83× | 1.91× | ||
| Q2 25 | 0.72× | 3.49× | ||
| Q1 25 | 2.51× | -5.66× | ||
| Q4 24 | -2.39× | 4.36× | ||
| Q3 24 | 4.27× | 4.72× | ||
| Q2 24 | 2.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
